Neuron
CME: Addressing the Core Issue: Presynaptic Modulation in Schizophrenia Using a Novel Class of Medication
Patient and provider
CME: How to Make Appropriate Treatment Decisions for Patients With Schizophrenia
LAI
CME: Expert Panel: Optimizing Use of Long-Acting Injectable Medications in People With Schizophrenia in Community Settings
Patient medication
Xanomeline-Trospium Chloride in Schizophrenia: Phase 3 Trial
Dr Meyer
Tailoring Treatment to Patient Goals and Providing the Clozapine Option as Standard of Care With Dr Jonathan M. Meyer
Providers looking at images
How Muscarinic Stimulation Works in Psychosis
brain waves
Questions on Novel Dopaminergic Agents For Schizophrenia